March 4, 2013 – Polyphor announces successful Phase I results for its Pseudomonas selective antibiotic POL7080.
June 12, 2012 – Polyphor and Boehringer Ingelheim announce MacroFinder® collaboration.
July 27, 2011 - Polyphor and Axxam announce EU funded R&D collaboration for the treatment of Type-2 Diabetes.
May 6, 2010 - Polyphor and Novartis announce PEMfinder® collaboration.
April 12, 2010 - Polyphor and Axxam SpA announce ion channel collaboration.
February 19, 2010 - Polyphor discovers a new class of antibiotics with a novel mode of action. New weapon in the fight against multi-drug resistant bacteria published in “Science” (click here for German version).